2023-08-17 07:35:00
Celltrion Pharmaceuticals Excluded from this merger
Merger price Celltrion 148,853 won, Healthcare 66,874 won
The final decision will be made at the next shareholders’ meeting in October.
Merger price Celltrion 148,853 won, Healthcare 66,874 won
The final decision will be made at the next shareholders’ meeting in October.
Celltrion announced on the 17th that it would absorb and merge with Celltrion Healthcare. Celltrion Pharmaceuticals was excluded from the proposed merger of the three listed companies of the Celltrion Group.
The merger price per share was determined at 148,853 won for Celltrion and 66,874 won for Celltrion Healthcare. As of August 16, the merger ratio was calculated as ▲the weighted arithmetic average closing price of the trading volume for the past month ▲weighted arithmetic average closing price of the trading volume for the recent week ▲the arithmetic average of the closing prices of the most recent day. The merger is carried out by allocating regarding 0.45 shares of Celltrion common stock for each common share of Trion Healthcare.
Celltrion revealed the purpose of the merger, saying that it will grow into a truly global Big Pharma that leaps forward with new drugs beyond biosimilars. To this end, Celltrion will ▲integrate assets for large-scale investment ▲strengthen cost competitiveness and differentiate products by integrating development-production-sales functions ▲enhance transparency and investor trust by simplifying the transaction structure.
The shareholders’ meeting to approve the merger will be held on October 23. The appraisal right exercise period is from October 23 to November 13. The merger date is December 28th.
Invest Chosun Paid Service Posted on August 17, 2023 at 16:35
1692258409
#Promoting #merger #Celltrion #Celltrion #HealthcareInvest #Chosun
